We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+20.63%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$954M
AUM Growth
-$18.2M
Cap. Flow
-$125M
Cap. Flow %
-13.14%
Top 10 Hldgs %
58.8%
Holding
50
New
7
Increased
9
Reduced
5
Closed
16

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$48.8M
2
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$32.9M
3
HCA icon
HCA Healthcare
HCA
+$29.3M
4
AZN icon
AstraZeneca
AZN
+$25.1M
5
A icon
Agilent Technologies
A
+$23.6M

Top Sells

Rank Stock Value
1
VHS
VANGUARD HEALTH SYS INC COM STK (DE)
VHS
+$41.5M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$31M
3
AGN
Allergan plc
AGN
+$25.2M
4
UHS icon
Universal Health Services
UHS
+$16.7M
5
UNH icon
UnitedHealth
UNH
+$13.1M

Sector Composition

Rank Sector Weight
1 Healthcare 77.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGLN
26
DELISTED
Magellan Health Services, Inc.
MGLN
$10.5M 1.1%
175,000
– –
CCRN
27
DELISTED
Cross Country Healthcare
CCRN
$9.33M 0.98%
1,540,000
– –
PLX icon
28
Protalix BioTherapeutics
PLX
$191M
$8.11M 0.85%
179,000
+29,000
+19% +$1.49M
ITMN
29
DELISTED
INTERMUNE INC
ITMN
$7.68M 0.81%
500,000
-850,000
-63% -$11.9M
BIOL
30
DELISTED
Biolase, Inc.
BIOL
$5.13M 0.54%
+217
New +$6.99M
UAM
31
DELISTED
Universal American Corp
UAM
$5.11M 0.54%
670,600
+150,200
+29% +$1.32M
XNPT
32
DELISTED
XENOPORT, INC.
XNPT
$4.6M 0.48%
+809,943
New +$4.23M
BLUE
33
DELISTED
bluebird bio
BLUE
$4.04M 0.42%
11,580
– –
ALNY icon
34
Alnylam Pharmaceuticals
ALNY
$27.5B
– –
-1,000,000
Closed -$31M
AMED
35
DELISTED
Amedisys
AMED
– –
-800,000
Closed -$9.3M
BSX icon
36
Boston Scientific
BSX
$69.5B
– –
-1,000,000
Closed -$9.27M
ELV icon
37
CALL
Elevance Health
ELV
$81.5B
– –
-650,000
Closed -$53.2M
RMTI icon
38
Rockwell Medical
RMTI
$28.4M
– –
-18,182
Closed -$7.22M
SPY icon
39
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-750,000
Closed -$120M
UHS icon
40
Universal Health Services
UHS
$10.2B
– –
-250,000
Closed -$16.7M
UNH icon
41
UnitedHealth
UNH
$376B
– –
-200,000
Closed -$13.1M
NTUS
42
DELISTED
Natus Medical Inc
NTUS
– –
-140,928
Closed -$1.92M
AGN
43
DELISTED
Allergan plc
AGN
– –
-200,000
Closed -$25.2M
WCG
44
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-166,050
Closed -$9.22M
ANTH
45
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$0 ﹤0.01%
50,000
+43,750
+700% +$1.36M
ALR
46
DELISTED
Alere Inc
ALR
– –
-500,000
Closed -$12.3M
IDIX
47
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
– –
-2,750,000
Closed -$9.93M
VHS
48
DELISTED
VANGUARD HEALTH SYS INC COM STK (DE)
VHS
– –
-2,000,000
Closed -$41.5M
BEAT
49
DELISTED
BioTelemetry, Inc.
BEAT
– –
-1,800,000
Closed -$10.6M
CELGZ
50
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
– –
-658,158
Closed -$4.88M
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Camber Capital Management held 50 positions worth $954M, down 1.9% from $972M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Camber Capital Management withdrew a net $125M in Q3 2013, closing 16 positions and reducing 5 holdings. Its most notable exit was VANGUARD HEALTH SYS INC COM STK (DE), an estimated $41.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 68% a quarter earlier.

Against the trend, Camber Capital Management opened a new position in MALLINCKRODT PUBLIC LIMITED COMPANY worth $33.1M.

  • Camber Capital Management's largest Q3 2013 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 750,000 shares worth $33.1M.
  • Camber Capital Management added most to Teva Pharmaceuticals in Q3 2013, an estimated $48.8M increase.
  • Camber Capital Management's biggest Q3 2013 reduction was INTERMUNE INC, cutting an estimated $11.9M.
  • Camber Capital Management fully exited VANGUARD HEALTH SYS INC COM STK (DE) in Q3 2013, selling an estimated $41.5M.
  • Camber Capital Management's ten largest holdings make up 59% of its $954M portfolio in Q3 2013.
  • Camber Capital Management opened 7 new positions and closed 16 in Q3 2013.
  • Camber Capital Management's portfolio value fell 1.9% quarter-over-quarter to $954M.

Based on Camber Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.